Pakistan latest patents query
The latest invention patents collect the data information of Pakistan invention patents from 2000 to 2024, typesetting according to the date of patent publication, including patent number, application date, invention Bibliographic data, abstracts, and specification data of people are convenient for scientific researchers to quickly browse and search for patents.
Novel (heterocycle-tetrahydropyridine)(piperazinyl)-1-alkanone and (heterocycle-dihydropyrrolidine)(piperazinyl)-1-alkanone derivatives, and use thereof as p75 inhibitor
UndeterminedPK201001030A0
Owner:SANOFI AVENTIS SA
Heterocyclic urea derivatives and methods of use thereof
UndeterminedPK201000738A0
Owner:ASTRAZENECA AB
Imadazole being fused to a 5- or 6-membered ring containing 0-2 further heteroatoms selected from N,O or S.
UndeterminedPK140890A
Owner:BAYER SCHERING PHARMA AG
Pharmaceutically acceptable salts of macrocyclic indole derivatives.
UndeterminedPK201000678A0
Owner:MERCK SHARP & DOHME CORP
An apparatus for treating a bed of particulate material supported by an aeration bottom
UndeterminedPK201000948A0
Owner:FISMITH AS
Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl] pyrimidin-5-yl}carbamate and its purification for use as pharmaceutically active compound
UndeterminedPK201000945A0
Owner:BAYER SCHERING PHARMA AG
Process for the synthesis of n-[2-(7-methoxy-1-naphthyl)ethyl]acetamide(agomelatine)
UndeterminedPK140892A
Owner:LES LAB SERVIER SA
Registration of inflatable bladder with multi layers of i.e. thread and woven material
UndeterminedPK201000941A0
Owner:SHOAIB JAHANGIR
Anticancer derivatives their preparation and their therapeutic application
UndeterminedPK201000731A0
Owner:SANOFI AVENTIS SA
A heat generator comprising magnetocaloric elements for industrial and domestic applications having an internal heat transfer fluid circuit
UndeterminedPK140928A
Owner:COOLTECH APPL SAS
A Diagnostic Method and Biomarker Panel for Detecting Varicocele-Associated Hypogonadism and Infertility Using Oxidative Stress Markers, Testicular Hyperthermia, and Seminal microRNA Signatures
PendingPK202600727A0
Owner:DR SHAHZAD IRFAN +6
A pharmaceutical composition containing at least one lipase inhibitor, at least one surfactant and at least one dispersant.
UndeterminedPK141028A
Owner:F HOFFMANN LA ROCHE & CO AG
Nylon-cotton fabric having high durability and breathability
UndeterminedPK201000906A0
Owner:INVISTA TECHNOLOGIES SARL(CH)
Process for the preparation of 4-(3-pyridinyl)-1h-imidazole.
UndeterminedPK140883A
Owner:AVENTIS PHARMA SA
Polysubstituted 2-aryl-6-phenyl-imidazo[1,2-a]pyridine compound
UndeterminedPK140995A
Owner:SANOFI AVENTIS SA
New process for the resolution of enantiomer of (3,4-dimethoxy-bicyclo [4.2.0] octa-1,3,5-trien-7-yl) nitrile and application in the synthesis of ivabradine
UndeterminedPK141012A
Owner:LES LAB SERVIER SA
Method for preparing crosslinked bitumen / polymer compositions without use of a crosslinking agent.
UndeterminedPK201000658A0
Owner:TOTAL RAFFINAGE MARKETING
Composition for Eco Friendly Polyurethane Foam using Ethyl Format as Blowing Agent
PendingPK202600745A0
Owner:NAT UNIV OF TECH NUTECH
Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency
UndeterminedPK201000804A0
Owner:EURAND PHAMACEUTICALS LTD
Process for the preparation of a dispersible tablet comprising 4-[3,5-bis(2-hydroxyphenyl)-[1,2,4]triazol-1-yl]benzoic acid.
UndeterminedPK201000674A0
Owner:NOVARTIS AG
Composition comprising methanesulfonate salt of ethyl 3-[(2- {[4 (hexyloxycarbonylamino-imino-methyl) phenylamino]- methy}-1-methyl-1H benzimidazole-5-carbonyl)-pyridin-2-ylamino]-propionate
UndeterminedPK140973A
Owner:BOEHRINGER INGELHEIM PHARMA GMBH & CO KG
Manually operated produce labeler tethered to an articulating, weight bearing boom and label supply
UndeterminedPK201000718A0
Owner:SINCLAIR SYSTEMS INTERNATIONAL LLC
Axmi-192 family of pesticidal genes and methods for their use.
UndeterminedPK201000671A0
Owner:ATHENIX CORP
Pharmaceutical composition containing Nmethyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)-ethyl]-2,2-diphenylacetamide.
UndeterminedPK140876A
Owner:MERCK PATENT GMBH
Solar Tracking System With The use of Two same sensors
UndeterminedPK201000977A0
Owner:ABDUL WAHAB KHAN AQEEL +4
Chiral processes for the preparation of matrix metalloproteinase inhibitor
UndeterminedPK201000811A0
Owner:RANBAXY LABORATORIES LTD
The use of an L3 and / or L5 source as a vaccine or as a diagnostic for a parasitic disease
UndeterminedPK201000955A0
Owner:SL UNIPERSONAL (A SPANISH CO)
Disubstituted [4-(5-aminomethyl pheny1)-piperidin-1- y1]-1 h- indo1 3-y1]-methanones
UndeterminedPK201000715A0
Owner:SANOFI AVENTIS SA
Gene Pyramiding and Hybrid Cotton Production of Pakistani Cotton Varieties
UndeterminedPK201000765A0
Owner:NAT CENT OF EXCELLENCE IN MOLECULAR BIOLOGY
A luminescent substance and a printed value document comprising thereof
UndeterminedPK140947A
Owner:GIESECKEDEVRIENT IP
Novel (heterocycle-fused piperidine)-(piperazinyl)-1-alkanone derivatives or (heterocycle-fused pyrrolidine)-(piperazinyl)-1-alkanone derivatives and use thereof as p75 inhibitors
UndeterminedPK201001031A0
Owner:SANOFI AVENTIS SA
Fused heterocyclic compounds as orexin receptor modulators.
UndeterminedPK201000882A0
Owner:JANSSEN PHARMA NV
Method and apparatus for analysis of amplitude-modulated broadband noise
UndeterminedPK201000782A0
Owner:ATLAS ELEKTRONIK GMBH
Preventing or reducing scale in wet process phosphoric acid production
UndeterminedPK201000825A0
Owner:CYTEC TECHNOLOGY CORP
Pharmaceutical composition comprising a strontium salt, vitamin D and a cyclodextrin
UndeterminedPK201000978A0
Owner:LES LAB SERVIER SA
A bacteriophage that has a specific bactericidal activity against salmonella gallinarum and salmonella pullorum
UndeterminedPK140981A
Owner:CJ CHEILJEDANG CORP
Use of 4[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease.
UndeterminedPK201000889A0
Owner:JOINT STOCK COMPANY GRINDEKS
Selective insecticidal composition comprising a combination of Substituted cyclic ketoenol and safener
UndeterminedPK140933A
Owner:BAYER CROPSCIENCE AG
Nano Polymer Retrofit for Blast Protection Application
UndeterminedPK140915A
Owner:DR MUHAMMAD BILAL KHAN PAKISTAN SCHOOL OF CHEMICAL & MATERIALS ENGINEERING (SCME) NATIONAL UNIVERSITY OF SCIENCE & TECHNOLOGY (NUST)
A pharmaceutical composition comprising one or more discrete solid orally deliverable dose units, each comprising particulate celecoxib
UndeterminedPK140953A
Owner:GD SEARLE & CO
An aqueous composition containing epinastin for use in the treatment of disease
UndeterminedPK141005A
Owner:BOEHRINGER INGELHEIM INT GMBH
A detergent bar comprising a first major side having a centrally disposed concave area, an opposed second major side , a first minor side and an opposed second minor side
UndeterminedPK140914A
Owner:UNILEVER PLC
Enhanced fertilizer products with polymer adjuvants
UndeterminedPK201000826A0
Owner:SPECIALTY FERTILIZER PRODUCTS LLC +1
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
UndeterminedPK201000973A0
Owner:ABBOTT LAB INC
Fabric-inspector: Smart Real Time Fabric Characterization and Quality Inspection System
PendingPK202600741A0
Owner:NED UNIV OF ENG & TECH
Hexahydrooxazinopterine compounds for use as mtor inhibitors
UndeterminedPK201000741A0
Owner:TAKEDA PHARMA CO LTD
Sprayable hydraulic binder composition and method of use
UndeterminedPK201000752A0
Owner:CONSTRUCTION RESEARCH & TECHNOLOGY GMBH
Antibodies that specifically bind to the epha2 receptor
UndeterminedPK201000834A0
Owner:SANOFI AVENTIS SA
Salts of 4-{[(2-oxo-2,3-dihydro-1h indo1-1-yl) carbonyl] amino} methyl) pireridin -1-y1 derivatives
UndeterminedPK201000714A0
Owner:PFIZER INC
Nitrogen-containing compound and pharmaceutical composition
UndeterminedPK201000719A0
Owner:OTSUKA PHARM CO LTD
Ophthalmic pharmaceutical compositions of dp2 receptor antagonists.
UndeterminedPK201000668A0
Owner:AMIRA PHARMA INC
PEGylated Berberine Chloride Hydrate-Loaded Silver Nanoparticles
PendingPK202600723A0
Owner:THE UNIV OF LAHORE
Specific binding proteins and uses thereof
UndeterminedPK201000835A0
Owner:LUDWIG INSTITUTE FOR CANCER RESEARCH LTD
Folding unit for pourable food product packaging machines.
UndeterminedPK201000693A0
Owner:TETRA LAVAL HOLDINGS & FINANCE SA
A packaging machine for producing sealed packages of pourable food products.
UndeterminedPK201000868A0
Owner:TETRA LAVAL HOLDINGS & FINANCE SA
Method and device for feeding powdered fuel into the combustor of an open cycle gas turbine.
UndeterminedPK201000684A0
Owner:KUO TSUNG HSIEN
Fiber-reactive azo dye and dye mixture.
UndeterminedPK141003A
Owner:DYSTOR TEXTILFARBEN GMBH & CO DEUTSCHLAND KG
A Novel Method for the Synthesis and Characterization of Zn-Mg Nanoparticles Doped on Rice Husk via Adsorption for the Removal of Tylosin Tartrate from Aqueous Samples
PendingPK202600744A0
Owner:DR MUHAMMAD IRFAN JALEES ASSOCIATE PROFESSOR +1
A process for the preparation of chemical from copper Minerals / ores using physical and chemical methods.
UndeterminedPK140999A
Owner:MRS IFFAT TAHIRA +2
Crystal of 1,2-dihydropyridine compound and its production process.
UndeterminedPK140998A
Owner:EISAI CO LTD
Morpholinothiazoles as alpha 7 positive allosteric modulators
UndeterminedPK201000980A0
Owner:JANSSEN PHARMA NV
Crystalline forms of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea and salts thereof
UndeterminedPK201001000A0
Owner:NOVARTIS AG
3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetylcholine receptor ligands
UndeterminedPK201001008A0
Owner:TARGACEPT INC
Substituted aminothiazolone indazoles as estrogen related receptor-a modulators
UndeterminedPK201001019A0
Owner:JANSSEN PHARMA NV
Salt of a substituted imidazol-2-yl piperidine compound.
UndeterminedPK201000871A0
Owner:ELI LILLY & CO
N-{[1,6-Diethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrozolo[3,4-b]pyridin-5-yl]methyl}-4-({8-[(2-hydroxyethyl) (methyl)amino]octanoyl}amino)benzamide ;pharmaceutical composition comprising said compound
UndeterminedPK141032A
Owner:GLAXO GROUP LTD
Novel polymorphic forms of methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate
UndeterminedPK201000946A0
Owner:BAYER SCHERING PHARMA AG
Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof
UndeterminedPK201000822A0
Owner:BOEHRINGER INGELHEIM INT GMBH
Integrated process for the production of vinyl acetate from acetic acid via ethylene
UndeterminedPK141013A
Owner:CELANESE INTERNATIONAL CORP
Substituted piperidines that increase p53 activity and the uses therof.
UndeterminedPK201000859A0
Owner:SCHERING CORP
Oilsuspensionconcentrate comprising herbicidally active compounds from the group of thienyl-sulfonamide
UndeterminedPK140942A
Owner:BAYER CROPSCIENCE AG
Marking based on modified chiral liquid crystal polymers
UndeterminedPK201001004A0
Owner:SICPA HOLDING SA
Pharmaceutical composition comprising a glp-1 agonist and methionine
ActivePK201000956A0
Owner:SANOFI AVENTIS DEUT GMBH
Thermostable B-1,4-glucosidase from thermotoga petrophila displaying highest ever reported enzyme Activity
ActivePK201000954A0
Owner:SANA MAJEED
Method and apparatus for finding the bearing of sound-emitting targets
UndeterminedPK201000783A0
Owner:ATLAS ELEKTRONIK GMBH
Insecticidal methods using nitrogen containing heteroaromatic compounds
UndeterminedPK201000979A0
Owner:BASF SE
Electroacoustic transducer, in particular a transmitting transducer
UndeterminedPK201000806A0
Owner:ATLAS ELEKTRONIK GMBH
Registration of inflatable bladder with layer of woven material
UndeterminedPK201000940A0
Owner:SHOAIB JAHANGIR
Modified marking based on chiral liquid crystal polymers
UndeterminedPK201001002A0
Owner:SICPA HOLDING SA
A pharmaceutical composition comprising parapdxvirus ovis in combination with classical cytotoxic chemotherapeutic agent as biochemotherapy.
UndeterminedPK140900A
Owner:AICURIS GMBH & CO KG
Acetylenic 5 phenylpyrazolopyridine derivatives, their preparation and their therapeutic application
UndeterminedPK201000801A0
Owner:SANOFI AVENTIS SA
Process for preparing a composition a gelling agent and 11-[4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]dibenzo-[b,f][1,4]thiazepine.
UndeterminedPK140905A
Owner:ASTRAZENECA UK LTD